Cargando…

Quality Control of Immunological Veterinary Medicinal Products in Europe

Medicinal products in Europe are under the strict control of many organisations headed by the European Directorate for the Quality of Medicines and HealthCare (EDQM) in Strasbourg and its related General European Official Medicines Control Laboratories (OMCLs) Network (GEON). The EDQM works in coope...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasik, Katarzyna, Łysiak, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950427/
https://www.ncbi.nlm.nih.gov/pubmed/31934671
http://dx.doi.org/10.2478/jvetres-2019-0075
_version_ 1783486069302362112
author Pasik, Katarzyna
Łysiak, Ewa
author_facet Pasik, Katarzyna
Łysiak, Ewa
author_sort Pasik, Katarzyna
collection PubMed
description Medicinal products in Europe are under the strict control of many organisations headed by the European Directorate for the Quality of Medicines and HealthCare (EDQM) in Strasbourg and its related General European Official Medicines Control Laboratories (OMCLs) Network (GEON). The EDQM works in cooperation with the European Medicines Agency (EMA) and the World Health Organisation (WHO). All of these institutions have one main goal – to protect public health in Europe and around the world. One of the more important effects of the harmonisation of pharmaceutical law in Europe was the introduction of the mutual recognition principle for the Official Control Authority Batch Release (OCABR)/Official Batch Protocol Review (OBPR) certificates in the European Union. The National Veterinary Research Institute (NVRI) in Poland is an example of an OMCL laboratory within the Veterinary Batch Release Network (VBRN) that issues the European certificates. The NVRI is actively involved in the batch release of immunological veterinary medicinal products (IVMPs), with approximately 1,800 certificates for IVMPs issued per year. It is also one of only four veterinary OMCLs that perform Post Marketing Surveillance (PMS) studies including approximately 47 IVMPs per year. All the results of the testing data are sent to the Chief Veterinary Officer, and also to the electronic Network platforms of the EDQM, which enables transparent information exchange.
format Online
Article
Text
id pubmed-6950427
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-69504272020-01-13 Quality Control of Immunological Veterinary Medicinal Products in Europe Pasik, Katarzyna Łysiak, Ewa J Vet Res Review Article Medicinal products in Europe are under the strict control of many organisations headed by the European Directorate for the Quality of Medicines and HealthCare (EDQM) in Strasbourg and its related General European Official Medicines Control Laboratories (OMCLs) Network (GEON). The EDQM works in cooperation with the European Medicines Agency (EMA) and the World Health Organisation (WHO). All of these institutions have one main goal – to protect public health in Europe and around the world. One of the more important effects of the harmonisation of pharmaceutical law in Europe was the introduction of the mutual recognition principle for the Official Control Authority Batch Release (OCABR)/Official Batch Protocol Review (OBPR) certificates in the European Union. The National Veterinary Research Institute (NVRI) in Poland is an example of an OMCL laboratory within the Veterinary Batch Release Network (VBRN) that issues the European certificates. The NVRI is actively involved in the batch release of immunological veterinary medicinal products (IVMPs), with approximately 1,800 certificates for IVMPs issued per year. It is also one of only four veterinary OMCLs that perform Post Marketing Surveillance (PMS) studies including approximately 47 IVMPs per year. All the results of the testing data are sent to the Chief Veterinary Officer, and also to the electronic Network platforms of the EDQM, which enables transparent information exchange. Sciendo 2019-12-19 /pmc/articles/PMC6950427/ /pubmed/31934671 http://dx.doi.org/10.2478/jvetres-2019-0075 Text en © 2019 K. Pasik, E. Łysiak et al. published by Sciendo http://creativecommons.org/licenses/by-nc-nd/3.0 This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
spellingShingle Review Article
Pasik, Katarzyna
Łysiak, Ewa
Quality Control of Immunological Veterinary Medicinal Products in Europe
title Quality Control of Immunological Veterinary Medicinal Products in Europe
title_full Quality Control of Immunological Veterinary Medicinal Products in Europe
title_fullStr Quality Control of Immunological Veterinary Medicinal Products in Europe
title_full_unstemmed Quality Control of Immunological Veterinary Medicinal Products in Europe
title_short Quality Control of Immunological Veterinary Medicinal Products in Europe
title_sort quality control of immunological veterinary medicinal products in europe
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950427/
https://www.ncbi.nlm.nih.gov/pubmed/31934671
http://dx.doi.org/10.2478/jvetres-2019-0075
work_keys_str_mv AT pasikkatarzyna qualitycontrolofimmunologicalveterinarymedicinalproductsineurope
AT łysiakewa qualitycontrolofimmunologicalveterinarymedicinalproductsineurope